Total Payments
$4,669
2024 Payments
$315.34
Companies
49
Transactions
203
Medicare Patients
9,274
Medicare Billing
$724,119
Payment Breakdown by Category
Food & Beverage$3,972 (85.1%)
Travel$569.80 (12.2%)
Education$127.56 (2.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,972 | 197 | 85.1% |
| Travel and Lodging | $569.80 | 3 | 12.2% |
| Education | $127.56 | 3 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Coloplast Corp | $852.15 | 8 | $0 (2019) |
| Astellas Pharma US Inc | $541.55 | 29 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $364.36 | 20 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $280.85 | 14 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $219.52 | 12 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $175.28 | 8 | $0 (2021) |
| PFIZER INC. | $166.74 | 11 | $0 (2024) |
| ABBVIE INC. | $165.00 | 6 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $154.08 | 7 | $0 (2021) |
| Boston Scientific Corporation | $133.90 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $315.34 | 13 | PFIZER INC. ($52.94) |
| 2023 | $185.24 | 8 | Endo Pharmaceuticals Inc. ($47.28) |
| 2022 | $699.83 | 36 | Bayer HealthCare Pharmaceuticals Inc. ($106.26) |
| 2021 | $758.08 | 39 | Bayer HealthCare Pharmaceuticals Inc. ($139.57) |
| 2020 | $364.60 | 19 | Endo Pharmaceuticals Inc. ($77.44) |
| 2019 | $432.19 | 25 | Astellas Pharma US Inc ($65.05) |
| 2018 | $645.11 | 27 | Astellas Pharma US Inc ($205.28) |
| 2017 | $1,269 | 36 | Coloplast Corp ($836.34) |
All Payment Transactions
203 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/10/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 09/10/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: UROLOGY | ||||||
| 08/27/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Oncology | ||||||
| 07/30/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Oncology | ||||||
| 06/06/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.18 | General |
| 02/15/2024 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: Wound Closure | ||||||
| 02/08/2024 | Boston Scientific Corporation | GreenLight XPS (Device) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: GreenLight_URO | ||||||
| 01/25/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $23.66 | General |
| 01/18/2024 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: UROLOGY | ||||||
| 10/03/2023 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Genetic Disease | ||||||
| 08/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Oncology | ||||||
| 06/27/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Oncology | ||||||
| 06/20/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Oncology | ||||||
| 05/11/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: UROLOGY | ||||||
| 04/06/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 03/07/2023 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Urology | ||||||
| 01/18/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: UROLOGY | ||||||
| 12/06/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Oncology | ||||||
| 10/06/2022 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: UROLOGY | ||||||
| 10/04/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Oncology | ||||||
| 09/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,089 | 3,133 | $1.2M | $162,274 |
| 2022 | 22 | 1,919 | 2,657 | $984,826 | $152,448 |
| 2021 | 26 | 1,977 | 2,612 | $1.2M | $205,661 |
| 2020 | 31 | 3,289 | 4,281 | $1.0M | $203,736 |
Total Patients
9,274
Total Services
12,683
Medicare Billing
$724,119
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 312 | 474 | $94,800 | $38,578 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 497 | 624 | $90,480 | $36,064 | 39.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 25 | 244 | $610,000 | $31,533 | 5.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $22,126 | $7,775 | 35.1% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 15 | 15 | $85,965 | $7,714 | 9.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 53 | $15,900 | $6,660 | 41.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 57 | 61 | $19,581 | $6,057 | 30.9% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 13 | 13 | $46,137 | $5,514 | 12.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 80 | $12,400 | $4,570 | 36.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 57 | 64 | $38,400 | $3,621 | 9.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 596 | 962 | $17,186 | $2,076 | 12.1% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 22 | 22 | $10,582 | $1,892 | 17.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 28 | 50 | $5,250 | $1,888 | 36.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $4,807 | $1,632 | 34.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 14 | 16 | $34,720 | $1,548 | 4.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 26 | 62 | $12,400 | $1,430 | 11.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 18 | $3,630 | $1,326 | 36.5% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 100 | 117 | $16,380 | $998.53 | 6.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 115 | 151 | $9,060 | $926.13 | 10.2% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 22 | 22 | $8,844 | $471.15 | 5.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 502 | 673 | $97,585 | $38,182 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 304 | 437 | $87,400 | $37,451 | 42.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 26 | 206 | $515,000 | $28,165 | 5.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 79 | 79 | $23,621 | $8,425 | 35.7% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2022 | 12 | 12 | $68,772 | $5,828 | 8.5% |
About Dr. Mark Phillips, M.D
Dr. Mark Phillips, M.D is a Urology healthcare provider based in Meridian, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1821124728.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Phillips, M.D has received a total of $4,669 in payments from pharmaceutical and medical device companies, with $315.34 received in 2024. These payments were reported across 203 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($3,972).
As a Medicare-enrolled provider, Phillips has provided services to 9,274 Medicare beneficiaries, totaling 12,683 services with total Medicare billing of $724,119. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Meridian, MS
- Active Since 02/26/2007
- Last Updated 10/24/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1821124728
Products in Payments
- FEMALE INCONTINENCE (Device) $739.06
- Nubeqa (Drug) $320.16
- XIAFLEX (Biological) $265.40
- PROVENGE (Drug) $218.18
- Myrbetriq (Drug) $205.16
- MYRBETRIQ (Drug) $197.15
- XTANDI (Drug) $166.74
- NUPLAZID (Drug) $154.08
- KYNMOBI (Drug) $146.78
- EMGALITY (Drug) $114.69
- ALTIS (Device) $93.83
- Lupron (Drug) $81.21
- APTIOM (Drug) $72.74
- Soliris (Drug) $66.99
- KEYTRUDA (Biological) $65.23
- Dhivy (Drug) $61.01
- NURTEC ODT (Drug) $58.58
- Aimovig (Biological) $57.02
- AUSTEDO (Drug) $56.98
- SpaceOAR (Device) $56.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Meridian
Dr. Maggie Vuturo, Md, MD
Urology — Payments: $14,498
Urology $14,498
Dr. John Greer, M.d, M.D
Urology — Payments: $11,631
Urology $11,631
Dr. Brian Auge, Md, MD
Urology — Payments: $7,062
Urology $7,062
Dr. Wade Muncey, M.d, M.D
Urology — Payments: $6,979
Urology $6,979
Dr. Michael Jacobson, M.d, M.D
Urology — Payments: $6,965
Urology $6,965
Dr. Dawn King, M.d, M.D
Urology — Payments: $6,832
Urology $6,832